Episode: 167 - M&A, IPO or SPAC: CEOs Share Exit Strategies and Lessons Learned Along the Way

Medtech Talk

内容由Healthegy提供。所有播客内容（包括剧集、图形和播客描述）均由 Healthegy 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

2y ago 1:01:32

MP3•单集首页

Geoff Pardo and three successful medtech CEOs who exited their companies through a different pathway— M&A, IPO, and SPAC—discuss the pros and cons of each. While market volatility is a given, Bruce Shook, Former President & CEO, Intact Vascular and Vesper Medical; Clint Carnell, Co-Founder & Chairman, OrangeTwist; Former CEO, BeautyHealth; and Leslie Trigg, CEO, Outset Medical agreed that successful CEOs keep their focus on delivering returns for their investors—whether private or public. If your company is solving a really important problem and is creating value for patients, you’ll ultimately succeed, Shook said. From there, Trigg pointed out, exit vehicles are simply different modes of transportation to the same place.
GUESTS:
Bruce Shook, Former President & CEO, Intact Vascular and Vesper Medical
Clint Carnell, Co-Founder & Chairman, OrangeTwist; Former CEO, BeautyHealth
Leslie Trigg, CEO, Outset Medical, Inc.

HOST:
Geoff Pardo, General Partner, Gilde Healthcare; Host, Medtech Talk podcast

LINKS:
Cambridge Healthtech Institute
Medtech Talk
Gilde Healthcare
OrangeTwist
Outset Medical

187集单集